Filter Results:
(5,476)
Show Results For
- All HBS Web
(5,476)
- People (17)
- News (2,072)
- Research (2,722)
- Events (2)
- Multimedia (215)
- Faculty Publications (2,069)
Show Results For
- All HBS Web
(5,476)
- People (17)
- News (2,072)
- Research (2,722)
- Events (2)
- Multimedia (215)
- Faculty Publications (2,069)
- 24 Jan 2018
- News
How to Get People Addicted to a Good Habit
- 03 Jun 2009
- Working Paper Summaries
It Is Okay for Artists to Make Money…No, Really, It’s Okay
- March 2014 (Revised February 2015)
- Case
Loki Capital Management
By: Joseph B. Fuller, Shikhar Ghosh and Matthew Preble
In December 2013, Michael Kane was preparing to launch his start-up's first hedge fund. While pleased with the development of the business, he wanted to address a few lingering issues before going any further. He debated whether or not to fire the company's chief... View Details
- 09 Jun 2024
- Blog Post
The EC Formula: MBA Class of 2024 Looks Back
anything at HBS. I came in with a plan and an idea of who I wanted to be post-HBS, but giving myself the time and space to explore, ask questions, and try new things turns out to be the best thing I ever did! HEALTH View Details
- Blog
The Chao Center: The Heart of HBS Executive Education
also supporting health care initiatives and U.S.-Asia cultural exchanges." In 2012, the Chao family donated US$40 million to Harvard Business School, supporting the construction of the Ruth Mulan Chu Chao... View Details
- Forthcoming
- Book
Innovating in Healthcare: Creating Breakthrough Tech, Services, Drugs, Products, and Business Models
Innovating in Healthcare offers effective approaches for designing, reworking, and implementing innovative healthcare services, products, and business models. It will help anyone working in healthcare service or product development, from hospitals to startups,... View Details
Keywords: Health Care and Treatment; Service Delivery; Product Development; Business Model; Innovation and Invention; Health Industry
Herzlinger, Regina E. Innovating in Healthcare: Creating Breakthrough Tech, Services, Drugs, Products, and Business Models. Boston, MA: John Wiley & Sons, forthcoming.
- 06 Jun 2023
- Cold Call Podcast
The Opioid Crisis, CEO Pay, and Shareholder Activism
- 22 Feb 2022
- News
Lack of Female Scientists Means Fewer Medical Treatments for Women
- January 2021 (Revised March 2021)
- Case
Serum Institute of India (SII): Racing to Save Lives During a Pandemic
By: Rohit Deshpandé, Anjali Raina and Rachna Chawla
The CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how... View Details
Keywords: Business Ethics; Healthcare; COVID-19; Vaccines; Family Business; Ethics; Health Care and Treatment; Health Pandemics; Leadership; Corporate Accountability; Fairness; Growth and Development Strategy; Health Industry; India; South Asia
Deshpandé, Rohit, Anjali Raina, and Rachna Chawla. "Serum Institute of India (SII): Racing to Save Lives During a Pandemic." Harvard Business School Case 521-028, January 2021. (Revised March 2021.)
- December 2022
- Article
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies
By: Pragya Kakani, Michael Chernew and Amitabh Chandra
Context: To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices, as is commonly done, instead of prices net of confidential rebates offered by manufacturers, which are... View Details
Kakani, Pragya, Michael Chernew, and Amitabh Chandra. "The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies." Journal of Health Politics, Policy and Law 47, no. 6 (December 2022): 629–648.
- Web
Strategy for Universities & Nonprofits - Institute For Strategy And Competitiveness
customers must be quantified and measured Social organizations often pursue multiple societal outcomes , which requires multiple measured goals Understanding the full costs of delivering outcomes is essential to ensure that true value is being created, e.g. cost per... View Details
- Web
The Essential Porter - Institute For Strategy And Competitiveness
Essential Guide to Competition & Strategy by Joan Magretta 2006 Harvard Business School Press Redefining Health Care: Creating Value-Based Competition on Results by Michael Porter & Elizabeth Olmsted Teisberg View Details
- 08 Oct 2020
- Research & Ideas
Keep Your Weary Workers Engaged and Motivated
maximizing productivity? How do we help employees with work/life balance?” “How to keep people engaged and connected and OPTIMISTIC in appropriate measure while so many have so many competing personal and business and health and family... View Details
Keywords: by Boris Groysberg and Robin Abrahams
- Web
Interviewing - Alumni
valuable opportunity for me to understand the exciting projects already underway. As I mentioned, I continue to be extremely interested in Alpha Galactic, particularly the AGO Division. My consulting background and health View Details
- 18 May 2023
- News
India's New Money Managers
When Priti Rathi Gupta (OPM 49, 2017) was 16 years old, her father handed her his investment portfolio and asked her what she could make of it. She was befuddled. "He realized that, although I had schooling in what we call commerce, I didn't really know much about... View Details
Keywords: Maureen Harmon
- 25 Apr 2023
- Cold Call Podcast
Using Design Thinking to Invent a Low-Cost Prosthesis for Land Mine Victims
- 17 Aug 2021
- News
Dispensing Justice: The Case for Legalizing Cannabis Nationally
- Web
Key Stakeholders - Institute For Strategy And Competitiveness
HBS ISC Health Care Health Care Value-Based Health Care View Details
- November 2020
- Teaching Note
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 221-031. When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA)... View Details
- 13 Jul 2020
- Research & Ideas
Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk
criminal justice reform, other issues like that, health care reform, but the nexus between corporate America and what Black America needs and the most, in my opinion, is employment. And so if we can do... View Details